Postpartum hemorrhage is the major killer of women in the developing world (one woman every four minutes dies this way). One of the key issues is the speed with which an anemic woman can lose her life if she is not provided life-saving care. Often women are lost in transit to a facility that could have provided the care. But what if you could ‘buy time’—stabilizing the woman until she reaches a higher level facility. This is the idea behind the NASG, a device that is a potential game changer for women’s survival. The NASG, also called the non-pneumatic anti-shock garment, is a medical device that externally wraps around a woman experiencing hemorrhage and ‘buys her time’--time to get to a higher level health facility with life-saving drugs and blood transfusion.Two key clinical studies of the LifeWrap device came out in late 2009—one from Nigeria and one from Egypt. Though much more could be written (and will be), to sum up, maternal mortality and morbidity was lower with the use of the NASG. The authors report that in both studies “the measured blood loss was significantly lower for women treated with the NASG: 78% lower in Nigeria and 50% lower in Egypt.” The study also found that uterine atony (failure of the uterus to contract)—and a major cause of postpartum hemorrhage—was the cause of hemorrhage in only 30% of the cases studied. The more that is understood about the reasons for postpartum hemorrhage the better.

Leave a comment

Comments will be approved before showing up.


Also in The Maternova Blog

The bubble CPAP reducing neonatal mortality by 27 percent
The bubble CPAP reducing neonatal mortality by 27 percent

September 04, 2024 2 min read

NIgerian experience with a pilot in 7 hospitals using the bubble CPAP.
Read More
DreamWarming, infant warming mattress, infant transport mattress, infant hypothermia solution
An innovation in the warm chain: The DreamWarmer

June 24, 2024 2 min read

The warming mattress (made up of strips of phase change material) can stay warm for 6 or more hours.  It is a flexible mattress that can be used in conjunction with skin to skin contact or with Kangaroo Mother Care.
Read More
antenatal corticosteroids expert advice from FIGO
Antenatal corticosteroids: FIGO states they should not be given “just in case”

June 06, 2024 2 min read

According to the American College of Obstetricians and Gynecologists (ACOG) and the International Federation of Gynecology and Obstetrics (FIGO), the administration of antenatal corticosteroids is recommended in women with a pregnancy between 24 and 34 weeks who are at risk of preterm birth within the next seven days.
Read More